Bank of New York Mellon Corp - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$138,000
+21.1%
10,2270.0%0.00%
Q3 2018$114,000
-72.8%
10,227
-88.0%
0.00%
Q4 2016$419,000
+8.8%
85,328
+10.0%
0.00%
Q3 2016$385,000
-10.0%
77,598
-7.7%
0.00%
Q2 2016$428,000
-26.5%
84,058
-17.7%
0.00%
Q1 2016$582,000
-36.0%
102,082
+16.4%
0.00%
Q4 2015$910,000
-40.3%
87,697
+6.3%
0.00%
Q3 2015$1,524,000
-22.3%
82,487
-18.2%
0.00%
-100.0%
Q2 2015$1,961,000
+17.4%
100,798
+6.1%
0.00%
Q1 2015$1,670,000
+7.5%
95,004
-2.2%
0.00%
Q4 2014$1,553,000
+33.2%
97,142
+4.9%
0.00%
Q3 2014$1,166,000
-54.6%
92,646
-43.6%
0.00%
Q2 2014$2,566,000
+138.3%
164,344
+100.3%
0.00%
Q1 2014$1,077,000
-18.0%
82,057
+0.4%
0.00%
Q4 2013$1,314,000
-53.3%
81,709
-51.6%
0.00%
Q3 2013$2,812,000
+186.1%
168,994
+73.0%
0.00%
Q2 2013$983,00097,6990.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
Cloverdale Capital Management, LLC 324,722$6,170,0003.39%
ALPINE ASSOCIATES MANAGEMENT INC. 1,233,589$23,437,0000.77%
Beryl Capital Management LLC 220,189$4,184,0000.77%
BERKLEY W R CORP 109,601$2,082,0000.44%
WATER ISLAND CAPITAL LLC 514,970$9,784,0000.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 91,411$1,737,0000.22%
DELTEC ASSET MANAGEMENT LLC 50,000$950,0000.21%
Versor Investments LP 113,905$2,164,0000.21%
ALGERT GLOBAL LLC 14,774$281,0000.16%
Hillsdale Investment Management Inc. 92,941$1,766,0000.16%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders